Cargando…
Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors
Head and neck squamous cell carcinoma (HNSCC) is characterized by a high mortality rate owing to very few available oncological treatments. For many years, a combination of platinum-based chemotherapy and anti-EGFR antibody cetuximab has represented the only available option for first-line therapy....
Autores principales: | Fasano, Morena, Perri, Francesco, Della Corte, Carminia Maria, Di Liello, Raimondo, Della Vittoria Scarpati, Giuseppina, Cascella, Marco, Ottaiano, Alessandro, Ciardiello, Fortunato, Solla, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391435/ https://www.ncbi.nlm.nih.gov/pubmed/34440249 http://dx.doi.org/10.3390/biomedicines9081045 |
Ejemplares similares
-
Role and targeting of anaplastic lymphoma kinase in cancer
por: Della Corte, Carminia Maria, et al.
Publicado: (2018) -
Mechanisms of resistance to EGFR-targeted drugs: lung cancer
por: Morgillo, Floriana, et al.
Publicado: (2016) -
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy
por: Fasano, Morena, et al.
Publicado: (2021) -
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy
por: Fasano, Morena, et al.
Publicado: (2015) -
Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer
por: Della Corte, Carminia Maria, et al.
Publicado: (2014)